603233.SS
603233.SS
CNE100002RG2
DASHENLIN PHARMACEUTICAL GROUP
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
21.37B EUR
17.12B EUR
20.25B EUR
20.07B EUR
Enterprise Value
22.07B EUR
17.01B EUR
18.52B EUR
19.06B EUR
Valuation Multiples
Trailing P/E
15.76x
15.84x
20.18x
21.07x
Forward P/E
12.34x
--
--
--
Price to Sales
0.76x
0.8x
0.97x
0.96x
Price to Book
2.76x
2.21x
2.57x
2.72x
EV/Revenue
0.79x
0.79x
0.88x
0.91x
EV/EBITDA
8.88x
7.75x
9.04x
14.57x
Price to FCF (P/FCF)
8.37x
6.93x
5.99x
4.77x
EV/FCF
8.65x
6.89x
5.48x
4.53x
FCF Yield
11.95%
14.42%
16.69%
20.97%
ende